Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
Abstract Background As the leading form of non-melanoma skin cancer, basal cell carcinoma (BCC) presents a considerable challenge to healthcare systems, owing to its widespread occurrence. Current treatment options, such as surgical excision, cryotherapy, and localized therapies like imiquimod or 5-...
Saved in:
Main Authors: | Aashna Jassal (Author), Khushboo Pathania (Author), Pankaj Kumar (Author), Deepender Kaushik (Author), Simran Dhingra (Author), Deepak B. Salunke (Author), Sandip V. Pawar (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
by: Deepender Kaushik, et al.
Published: (2020) -
Biocomposites
Published: (2022) -
First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony.
by: Cesar Miranda-Verastegui, et al.
Published: (2009) -
Biocomposites Recent Advances
Published: (2023) -
Antimicrobial Potential of Conjugated Lignin/Morin/Chitosan Combinations as a Function of System Complexity
by: Zvezdelina Yaneva, et al.
Published: (2022)